Lawyers for stomach paralysis caused by Ozempic and other weight loss drugs
Have you or a loved one suffered gastrointestinal issues after taking Ozempic or another weight loss drug and required emergency room treatment or hospitalization? If so, you may be entitled to significant compensation. These medications are increasingly prescribed both to treat diabetes and encourage weight loss, but they potentially come with risks their manufacturers did not sufficiently make clear in their warning labels. At Farris, Riley & Pitt, LLP, we have been carefully monitoring the legal developments concerning Mounjaro, Ozempic, Wegovy, Rybelsus and Saxenda, and we are ready to help you pursue justice and compensation for your injuries.
Call (205) 324-1212 now for a 100% free review of your case by one of our weight loss drug injury lawyers.
The risks of Ozempic and similar weight loss drugs: What you need to know
The pharmaceutical drug Ozempic is widely prescribed for weight loss but was initially developed to manage diabetes and improve blood sugar levels. While it has been effective for many patients, others have reported experiencing severe gastrointestinal complications after taking Ozempic and other similar drugs. As of July 2023, the FDA has received thousands of reports of severe side effects and injuries in relation to Mounjaro, Ozempic, Wegovy, Rybelsus and Saxenda. These complications may include gastroparesis (delayed stomach emptying) or stomach paralysis, leading to severe discomfort, pain, and potential long-term health impacts.
Your Health is Our Priority: Understanding the Side Effects
Many of the most common side effects associated with Ozempic and other weight loss drugs are relatively mild, including:
- Nausea and vomiting
- Abdominal pain and discomfort
- Bloating and indigestion
- Diarrhea or constipation
However, clinicians have encountered more severe side effects in some patients, including:
- Persistent vomiting for at least four weeks (while on drug or close in time to stopping drug)
- Gastroparesis
- Stomach paralysis (“frozen” stomach)
- Bowel obstruction
- Gallbladder removal
- New onset of suicidal ideation or suicide attempt while on drug
- Death
Concerningly, the companies that produce these drugs – Novo Nordisk in the case of Ozempic and Eli Lilly for Mounjaro – may not have appropriately warned consumers of the risks associated with their products.
Take Action
You are not alone. If you or someone close to you has experienced any of the above side effects or other stomach-related complications after using Mounjaro, Ozempic, Wegovy, Rybelsus, or Saxenda, the time to act is now. The experienced team of dangerous drug injury lawyers at Farris, Riley & Pitt, LLP is dedicated to helping clients seek justice and compensation for their injuries. Call (205) 324-1212 now for a 100% free review of your case.
Why choose Farris, Riley & Pitt, LLP?
At Farris, Riley & Pitt, LLP, we understand the pain and anguish you’re likely facing due to weight loss drug-related health issues. That’s because we’ve helped many clients with similar problems over our three decades in practice and have seen first-hand the consequences of unsafe pharmaceuticals. We are committed to providing compassionate, personalized, and knowledgeable legal representation for the victims of dangerous medication, and we are ready to put them to work for you.
We offer:
- Free Case Evaluations: Get a 100% free, thorough assessment of your case without any upfront costs or obligations.
- An Experienced Legal Team: Our attorneys have a proven track record of handling complicated pharmaceutical injury cases.
- Personalized Attention: We treat each client like we would treat our own family. Our attorneys and support staff are dedicated to providing the care and understanding your unique case deserves.
Contact Us
If you or a loved one have suffered severe complications after taking Mounjaro, Ozempic, Wegovy, Rybelsus, or Saxenda, Farris, Riley & Pitt, LLP can help. Contact our experienced stomach paralysis lawyers online or at (205) 324-1212 for a free, no-obligation consultation.